JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 2 260-262
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiting, J. H.
Right arrow Articles by Miller, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiting, J. H., Jr.
Right arrow Articles by Miller, F. J., Jr.

Embolization of Hepatic Arteriovenous Malformations Using Radiolabeled and Nonradiolabeled Polyvinyl Alcohol Sponge in a Patient with Hereditary Hemorrhagic Telangiectasia: Case Report

John H. Whiting, Jr., Kathryn A. Morton, Frederick L. Datz, Gregory G. Patch and Franklin J. Miller, Jr.

Department of Radiology, Division of Nuclear Medicine, University of Utah School of Medicine, Salt Lake City, Utah

Correspondence: For reprints contact: Frederick L. Datz, MD, Nuclear Medicine Division, University of Utah Medical Center, 50 North Medical Dr., Salt Lake City, UT 84132.

ABSTRACT

Polyvinyl alcohol sponge (PVA) radiolabeled with 99mTc-sulfur colloid was used to evaluate a large hepatic arteriovenous malformation (AVM) in a 71-yr-old white female prior to embolization. The patient had hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) with severe left-to-right shunting through the hepatic AVM which resulted in high-output congestive heart failure. The patient also had severe pulmonary hypertension. Scintigraphic imaging of the embolized radiolabeled PVA particles allowed us to be certain that the particles did not flow through the liver and inadvertently embolize the lungs; with the patient's already poor pulmonary status, embolization could have been fatal.




This article has been cited by other articles:


Home page
NEJMHome page
G. Garcia-Tsao, J. R. Korzenik, L. Young, K. J. Henderson, D. Jain, B. Byrd, J. S. Pollak, and R. I. White
Liver Disease in Patients with Hereditary Hemorrhagic Telangiectasia
N. Engl. J. Med., September 28, 2000; 343(13): 931 - 936.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
F. J. Miller Jr, J. H. Whiting, J. R. Korzenik, R. I. White, A. Chavan, M. Galanski, S. Wagner, M. Caselitz, H. J. Schlitt, K. F. Gratz, et al.
Caution with Use of Hepatic Embolization in the Treatment of Hereditary Hemorrhagic Telangiectasia • Drs Chavan and colleagues respond:
Radiology, December 1, 1999; 213(3): 928 - 930.
[Full Text]


Home page
GutHome page
M Caselitz, S Wagner, A Chavan, M Gebel, J S Bleck, A Wu, H J Schlitt, M Galanski, and M P Manns
Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease)
Gut, January 1, 1998; 42(1): 123 - 126.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.